Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cannara Biotech Inc V.LOVE

Alternate Symbol(s):  LOVFF

Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations, which encompasses the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and other cannabis services (Cannabis operations). The Real estate operations, related to the Farnham and Valleyfield building (Real estate operations). The Company’s brand portfolio includes Tribal, Nugz, and Orchid CBD. Orchid CBD is a wellness brand that provides premium CBD-dominant cannabis.


TSXV:LOVE - Post by User

Post by PotLuck444on Jul 13, 2021 5:46am
364 Views
Post# 33534605

Love Investissement 5 millions $$$ at 18 cents..

Love Investissement 5 millions $$$ at 18 cents..

2021-07-09 09:39 ET - News Release

 

Mr. Nicholas Sosiak reports

CANNARA BIOTECH INC. COMPLETES ADDITIONAL $5 MILLION PRIVATE PLACEMENT

Cannara Biotech Inc. has closed an additional $5-million private placement at an issue price per share of 18 cents, resulting in the issuance of 27,777,778 new common shares in the capital of the company. This follows the company's previously announced acquisition of the one-million-square-foot licensed cultivation and manufacturing facility in Valleyfield, Que., and the two non-brokered private placements, which, through a combination of common shares and a convertible debenture, raised a total of $25-million to pay, in part, for the cost of the acquisition.

<< Previous
Bullboard Posts
Next >>